Founder, CEO & Chairman
Ishay is the founder of the company and serves as CEO & Chairman, leading it from an idea to a well-established, fast growing company. He has 20 years of experience leading the development of innovative technologies that address large un-met medical needs such as tissue reconstruction, surgical repair, diabetes, glaucoma, dry eye syndrome, and COPD. Ishay was the founder and CEO of LifeBond, a biosurgery startup which was acquired in 2019 by BD-Bard (BDX on NYSE).
He holds an MBA, M.Sc in Biomedical engineering, and B.Sc in Biotechnology engineering, all from the Technion, Israel Institute of Technology.
